Pediatric Transplantation

Dual monoclonal antibody therapy for the treatment of PTLD?
pp. 337-338(2)

Preventing acute and chronic rejection after diagnosis of post-transplantation lymphoproliferative disorder
pp. 339-341(3)

Is decreased bone mineral density in pediatric transplant recipients really a problem?
pp. 342-344(3)

The potential impact of SARS on organ transplantation: Exercise caution
pp. 345-347(3)

Facilitating cells as a venue to establish mixed chimerism and tolerance
pp. 348-357(10)
Authors: Jacquet E.G.; Schanie C.L.; Fugier-Vivier I.; Willer S.S.; Ildstad S.T.

Decreased bone mineral density in the pediatric renal transplant population
pp. 358-363(6)
Authors: Acott P.D.; Crocker J.F.S.; Wong J.A.

Survival of childhood polycystic kidney disease following renal transplantation: The impact of advanced hepatobiliary disease
pp. 364-369(6)
Authors: Davis I.D.; Ho M.; Hupertz V.; Avner E.D.

Lymphocyte subsets may discern treatment effects in children and young adults with post-transplant lymphoproliferative disorder
pp. 370-375(6)
Authors: LeVasseur R.; Ganjoo J.; Green M.; Janosky J.; Reyes J.; Mazariegos G.; Sindhi R.

Use of prophylactic lamivudine and mycophenolate mofetil in renal transplant recipients with chronic hepatitis B infection
pp. 376-380(5)
Authors: Lau S.C.; Tse K.C.; Lai W.M.; Chiu M.C.

Immediate tracheal extubation of pediatric liver transplant recipients in the operating room
pp. 381-384(4)
Authors: Ulukaya S.; Arkan Ç.; Aydodu S.; Ayanoglu H.O.; Tokat Y.

Cognitive and emotional outcome after pediatric liver transplantation
pp. 385-389(5)
Authors: Adebäck P.; Nemeth A.; Fischler B.

Psychological functioning of pediatric lung transplant candidates/recipients: A review of the literature
pp. 390-394(5)
Author: Brosig C.L.

Nephrotic syndrome after conversion to alternate day steroids in two children with a history of recurrent FSGS
pp. 395-399(5)
Authors: Hanevold C.D.; Greenbaum L.A.

Fatal pulmonary thromboembolism after a second course of high-dose chemotherapy with autologous peripheral blood stem cell transplantation
pp. 400-403(4)
Authors: Kounami S.; Aoyagi N.; Nakayama K.; Yoshiyama M.; Boshi H.; Sakiyama M.; Takeuchi T.; Yoshikawa N.

Basiliximab monotherapy following B-cell lymphoma after pediatric liver transplantation and anti-CD20 therapy
pp. 404-407(4)
Authors: Venzke A.; Ganschow R.; Grabhorn E.; Rogiers X.; Burdelski M.

End-stage renal disease after high-dose carboplatinum in preparation of autologous stem cell transplantation
pp. 408-412(5)
Authors: Butani L.; West D.C.; Taylor D.S.

Bordetella bronchiseptica infection in pediatric lung transplant recipients
pp. 413-417(5)
Authors: Ner Z.; A. Ross L.; Horn M.V.; Keens T.G.; MacLaughlin E.F.; Starnes V.A.; Woo M.S.